UBS sees cost savings as key benefit of Olin-Huntsman merger

UBS sees cost savings as key benefit of Olin-Huntsman merger
Olin, Huntsman to combine in all-stock merger of equals
The New York Post: Jon Huntsman to halt family foundation donations to alma mater Penn over Hamas-Israel ‘silence’
2BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4470111075
CUSIP
447011107
Sector
Basic Materials
Industry
Chemicals
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
2.22
Book Value
15.47
Dividend Share
0.675
Dividend Yield
5.91%
Earnings Share
-1.97
Wall Street Target Price
13.58
EPS Estimate Current Year
-0.18
EPS Estimate Next Year
0.19
EPS Estimate Current Quarter
-0.2053
EPS Estimate Next Quarter
-0.0741
Most Recent Quarter
-
Revenue TTM
5,693,000,192
Gross Profit TTM
733,000,000
EBITDA
254,000,000
Profit Margin
-5.83%
Return On Assets TTM
-0.19%
Return On Equity TTM
-8.89%
Revenue Per Share TTM
32.955
Qtly Revenue Growth YOY
0.70%
Diluted Eps TTM
-1.97
Qtly Earnings Growth YOY
20.60%
Trailing PE
0.00
Forward PE
153
Price Sales TTM
0.3685
Price Book MRQ
0.7477
Enterprise Value Revenue
0
Enterprise Value EBITDA
33
36.77
5.24%30.49
1.51%79.34
0.00%34.64
-6.02%4.48
-4.07%56.29
-3.22%17.94
-2.55%14.52
-2.02%17.92
-1.70%850.50
-0.18%